CBS 2019
CBSMD教育中心
中 文

Scientific Library

Abstract

Recommended Article

Aggressive lipid-lowering therapy after percutaneous coronary intervention – for whom and how? Fine particulate air pollution and hospital admissions and readmissions for acute myocardial infarction in 26 Chinese cities Patterns of use of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers among patients with acute myocardial infarction in China from 2001 to 2011: China PEACE-Retrospective AMI Study Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk Comparison of the Preventive Efficacy of Rosuvastatin Versus Atorvastatin in Post-Contrast Acute Kidney Injury in Patients With ST-segment Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes Mild Hypothermia in Cardiogenic Shock Complicating Myocardial Infarction - The Randomized SHOCK-COOL Trial Effect of a Restrictive vs Liberal Blood Transfusion Strategy on Major Cardiovascular Events Among Patients With Acute Myocardial Infarction and Anemia: The REALITY Randomized Clinical Trial

Expert OpinionVolume 12, Issue 6, June 2019

JOURNAL:JACC: Cardiovascular Imaging Article Link

Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging?

LJ Shaw, JK Min, Y Chandrashekhar. Keywords: biomarker; CAD; hsTnI; coronary Imaging; high risk plaque;

FULL TEXT PDF